Papers
1
Total Citations
1
H-Index
1
About
Hyun A Kim is a leading gynecologic oncologist whose research centers on fertility-sparing surgical treatments for early-stage cervical cancer, with a particular focus on integrating neoadjuvant chemotherapy with minimally invasive techniques. Her most cited work, a 2022 study on neoadjuvant chemotherapy with cisplatin-VP 16 followed by robotic radical trachelectomy for FIGO 2018 stage IB2 cervical cancer, addresses a critical clinical challenge: preserving fertility in women with larger tumors who traditionally would undergo radical hysterectomy. This case report demonstrates how combining chemotherapy with robotic surgery can expand fertility-sparing options for patients with stage IB2 disease, a contribution that has gained attention as delayed childbearing becomes more common. While her citation count is still growing, Kim’s work is notable for pushing the boundaries of what is surgically and oncologically possible—offering young women with cervical cancer a chance at both cure and future childbearing. Her research sits at the intersection of oncology, reproductive health, and surgical innovation, making her a valuable voice in the evolving conversation around personalized, function-preserving cancer care.
Research Focus
Key Achievements
Top Papers
- 1